Государственное Учреждение "Институт Педиатрии, Акушерства И Гинекологии Намн Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Педиатрии, Акушерства И Гинекологии Намн Украины"filedCriticalГосударственное Учреждение "Институт Педиатрии, Акушерства И Гинекологии Намн Украины"
Priority to UAU201101985UpriorityCriticalpatent/UA62429U/en
Publication of UA62429UpublicationCriticalpatent/UA62429U/en
A method for preventing the recurrence of the hyperplastic process in endometrium provides for the basic therapy. Furthermore, Sumamed is used as antibacterial drug at a daily dose of 500 mg once a day followed by 250 mg for 10 days and Isoprinosin is used as antiviral and immunomodulating drug at a daily dose of 50 mg/kg for 60 days. Tazaloc as herbal-based composition is used at the average therapeutic doses for 3 months providing for the recovery of the adequate phase sequence in the structure of endometrium.
UAU201101985U2011-02-212011-02-21Method for preventing recurrence of hyperplastic process in endometrium
UA62429U
(en)